Razadyne is a prescription drug approved by the Food and Drug Administration (FDA) to treat mild to moderate dementia associated with Alzheimer’s disease. Razadyne is also referred to by its drug name, Galantamine. Razadyne is sometimes prescribed along with Namenda[LINK], another drug used to treat cognitive symptoms of Alzheimer’s.
Razadyne is a cholinesterase inhibitor. Razadyne is believed to work by slowing the breakdown of a neurotransmitter in the brain.
How do I take it?
Prescribing information states that Razadyne is generally taken once or twice a day in the morning and/or evening.
Razadyne comes in tablet, extended-release capsule, and oral solution forms.
The FDA-approved label for Razadyne lists common side effects including nausea, diarrhea, vomiting, loss of appetite, weight loss, headache, and dizziness.
Rare but serious side effects listed for Razadyne include severe skin reactions, heart problems, and seizures.